bpc 157 fda warning unapproved peptide peptides bpc-157 tb-500 ipamorelin cjc-1295 BPC-157 BPC-157 Before the FDA: Briefing
Description
Indications: In adults, for the treatment of cervical dystonia
Published material on the related Pliva development codes PL-10, PLD-116, and PL-14736 has concentrated on preclinical wound, tissue-protection, and gastrointestinal-injury models rather than randomized human efficacy data, and the peer-reviewed record does not contain a confirmatory efficacy readout for the indications most commonly associated with BPC-157 in informal discussion
The website is easy to use, and delivery is fast
Did not achieve what the product promised
Torres JL, Ozorowski G, Andreano E, Liu H, Copps J, Piccini G, et al
